http://www.schizophrenia.com/szresearch/ Hosted by Farzin Irani (PHD candidate), and Jacob Ballon, (MD candidate).]]> en-us 2005-02-28T23:09:16+00:00 http://www.schizophrenia.com/szresearch/archives/001471.html Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Lewis DA, Volk DW, Hashimoto T. Psychopharmacology (Berl). 2004 Jun;174(1):143-50. Epub 2003 Dec 09. This article is about research being done... Jacob 2005-02-28T23:09:16+00:00 http://www.schizophrenia.com/szresearch/archives/001440.html Assessing the Validity of Blood-Based Gene Expression Profiles for the Classification of Schizophrenia and Bipolar Disorder: A Preliminary Report Ming T. Tsuang, Nadine Nossova, Tom Yager, Min-Min Tsuang, Shi-Chin Guo, Kou Ge Shyu, Stephen J. Glatt, and C.C. Liew American... Jacob 2005-02-21T19:55:02+00:00 http://www.schizophrenia.com/szresearch/archives/001437.html Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Am J Psychiatry. 2005 Jan;162(1):79-91. Introduction: Some studies have suggested that women with... Farzin 2005-02-19T15:16:37+00:00 http://www.schizophrenia.com/szresearch/archives/001397.html Targeting synapses and myelin in the prevention of schizophrenia. Woo TU, Crowell AL. Schizophr Res. 2005 Mar 1;73(2-3):193-207. There are many research efforts that are trying to understand how the brain works and how it develops in order to try... Farzin 2005-02-08T00:14:55+00:00 http://www.schizophrenia.com/szresearch/archives/001368.html Wirshing DA, Sergi MJ, Mintz J. A videotape intervention to enhance the informed consent process for medical and psychiatric treatment research. Am J Psychiatry. 2005 Jan;162(1):186-8. Wirshing DA, Wirshing WC, Marder SR, Liberman RP, Mintz J. Informed consent: assessment of... Jacob 2005-01-25T22:45:09+00:00 http://www.schizophrenia.com/szresearch/archives/001362.html Prodromal interventions for schizophrenia vulnerability: the risks of being "at risk". Corcoran C, Malaspina D, Hercher L. Schizophr Res. 2005 Mar 1; 73(2-3):173-84. Researchers have been trying to identify and treat teenagers and young adults who may be clinically at... Farzin 2005-01-23T23:28:15+00:00 http://www.schizophrenia.com/szresearch/archives/001337.html Association between short birth intervals and schizophrenia in the offspring. Smits L, Pedersen C, Mortensen P, van Os J. Schizophr Res. 2004 Sep 1;70(1):49-56. Background: Conceiving immediately after delivering a baby has been found to increase risk for premature births,... Farzin 2005-01-12T15:00:20+00:00 http://www.schizophrenia.com/szresearch/archives/001294.html New Perspectives in the Studies on Endocannabinoid and Cannabis: Cannabinoid Receptors and Schizophrenia Hiroshi Ujike and Yukitaka Morita J Pharmacol Sci 96, 376 – 381 (2004) This article reviews the evidence of cannabis (marijuana) with respect to psychosis and schizophrenia.... Jacob 2004-12-30T00:03:30+00:00 http://www.schizophrenia.com/szresearch/archives/001288.html Reliability of psychiatric diagnosis in postmortem research. Deep-Soboslay A, Akil M, Martin CE, Bigelow LB, Herman MM, Hyde TM, Kleinman JE. Biol Psychiatry. 2005 Jan 1;57(1):96-101. Background: To further understand how the brain works in various diseases, postmortem (after death)... Farzin 2004-12-28T14:46:13+00:00 http://www.schizophrenia.com/szresearch/archives/001274.html Effectiveness and Cost of Olanzapine and Haloperidol in the Treatment of Schizophrenia: A Randomized Controlled Trial Robert Rosenheck; Deborah Perlick; Stephen Bingham; Wen Liu-Mares; Joseph Collins; Stuart Warren; Douglas Leslie; Edward Allan; E. Cabrina Campbell; Stanley Caroff; June Corwin; Lori... Jacob 2004-12-24T05:49:45+00:00 http://www.schizophrenia.com/szresearch/archives/001273.html Paternal age and risk of developing schizophrenia Nobody knows why certain people get schizophrenia. However, there are many possibilities that have been investigated. There is evidence of a genetic component to developing schizophrenia, but that precise link is currently under... Jacob 2004-12-23T21:13:25+00:00 http://www.schizophrenia.com/szresearch/archives/001272.html Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: a double-blind placebo-controlled study M. C. Jockers-Scherübl, A. Bauer, F. Godemann, F. M. Reischies, F. Selig and P. Schlattmann International Clinical Psychopharmacology 2005, 20:27–31 Schizophrenia is often... Jacob 2004-12-23T18:44:01+00:00 http://www.schizophrenia.com/szresearch/archives/001270.html A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia A. Bechdolf, B. Knost, C. Kuntermann, S. Schiller, J. Klosterkötter, M. Hambrecht, R. Pukrop Acta Psychiatrica Scandinavica Volume 110 Issue 1 Page 21 (July 2004) Cognitive... Jacob 2004-12-23T06:27:01+00:00 http://www.schizophrenia.com/szresearch/archives/001268.html 1. Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial Jari Tiihonen, Tero Hallikainen, Olli-Pekka Ryynänen, Eila Repo-Tiihonen, Irma Kotilainen, Markku Eronen, Päivi Toivonen, Kristian Wahlbeck and Anu Putkonen Biological Psychiatry Volume 54, Issue 11 , 1 December 2003, Pages... Jacob 2004-12-22T20:38:38+00:00 http://www.schizophrenia.com/szresearch/archives/001266.html Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients István Bitter, Bruce R. Basson and Martin R. Dossenbach International Clinical Psychopharmacology 2005, 20:19–21 This small study attempts to determine if particular antipsychotic medications have a more significant impact on... Jacob 2004-12-21T23:50:30+00:00